2 weeks Ago
akinbostanci The U.S. Food and Drug Administration said on Friday that it has approved Sanofi's ( SNY ) Qfitlia to treat bleeding in patients aged 12 and older with hemophilia A or B, with or without factor VIII or IX inhibitors.
The approval.
